Health
Diabetes vaccine gives promising results in a genetic subgroup – EurekAlert
A clinical study led by Linköping University, Sweden, and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type…
IMAGE: Johnny Ludvigsson, senior professor at Linköping University.
view more
Credit: Anna Nilsen/Linköping University
A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body’s own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes can be effective in a subgroup of individuals. The results have been published in Diabetes Care.
…
-
Business24 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General20 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News15 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News24 hours agoAusgold acquires 860ha of farmland for Katanning Gold Project